All GILD Content

Gilead Sciences, Inc (GILD) Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release

April 7, 20261 min read

Gilead Sciences, Inc (GILD) Gilead Extends Tender Offer to Acquire Arcellx

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 M&A Release

April 2, 20261 min read

Gilead Sciences, Inc (GILD) Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release

March 23, 20261 min read

Gilead Sciences, Inc (GILD) Q4 2025 Earnings Call Transcript

Gilead Sciences, Inc (NASDAQ: GILD) Q4 2025 Earnings Call dated Feb. 10, 2026 Corporate Participants: Jacquie Ross — Senior Vice...

March 10, 202646 min read

Gilead Sciences, Inc (GILD) Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release

March 2, 20261 min read

Gilead Sciences, Inc (GILD) Sec Form 10K

Gilead Sciences, Inc (NASDAQ: GILD) Sec Form 10K

February 26, 20261 min read

Gilead Sciences, Inc (GILD) Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release

February 25, 20261 min read

Gilead Sciences, Inc (GILD) Sec Form 8K

Gilead Sciences, Inc (NASDAQ: GILD) Sec Form 8K

February 24, 20261 min read

Gilead Sciences, Inc (GILD) Barclays Annual Global Healthcare Conference

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Corporate Conference

February 23, 20261 min read

Gilead Sciences, Inc (GILD) Leerink Partners Global Healthcare Conference

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Corporate Conference

February 23, 20261 min read